Brief: Celltrion Says Awarded Up To $626 Mln From Department Of Defense To Supply Covid-19 Point-Of-Care Rapid Antigen Test Kits
23/09/2021 08:20
Sept 23 (Reuters) - Celltrion Inc 068270.KS :
* CELLTRION AWARDED UP TO $626 MILLION FROM THE DEPARTMENT
OF
DEFENSE TO SUPPLY COVID-19 POINT-OF-CARE (POC) RAPID ANTIGEN
TEST KITS
Source text for Eikon: ID:nBw33Fpw1a
Further company coverage: 068270.KS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Celltrion
See all newsBrief: Celltrion, Q3 Operating. Profit 510 Billion Won, Up 69% Y/Y
Brief: Celltrion, To Buy 100 Billion Won Worth Of Own Shares
Brief: Celltrion Sets Mid-To-Long Term Shareholder Return Target To One-Third Of Net Profit
South Korean chip stocks rally, tracking US AI gains; Temasek report adds support
Brief: Celltrion Q2 Operating Profit Rises 77.3% Y/Y To 430 Billion Won